|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 39/395 | |||
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 2995625 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15177075.7 |
| Date of filing the European patent application | 2009-02-27 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 32707 P | 2008-02-29 | US | |
| 90743 P | 2008-08-21 | US |
| (72) |
MÜLLER, Bernhard K., DE
SCHMIDT, Martin, DE
BARLOW, Eve H., US
LEDDY, Mary R., US
HSIEH, Chung-Ming, US
BARDWELL, Phillip D., US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
Abbvie Deutschland GmbH & Co. KG, Max-Planck-Ring 2a, 65205 Wiesbaden, DE |
| (54) | MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF |
| MONOCLONAL ANTIBODIES AGAINST THE RGM A PROTEIN AND USES THEREOF |